The European Research Council (ERC) has announced the results of its latest Consolidator Grant competition, selecting 349 mid-career researchers for a combined €728 million in funding.
A major clinical trial has found that low-dose interleukin-2 (IL2LD) is safe and may significantly extend survival in people with motor neurone disease (ALS).
A neuroscience mystery has been solved by using artificial intelligence (AI) to identify the electrical signatures of different types of brain neurons for the first time.
A new study by the University of Manchester has found that a new clotbusting drug is significantly better at treating ischemic stroke than existing treatments.
Dr Sung Min Son and Prof David Rubinsztein (UK DRI at Cambridge) have identified a key enzyme driving forms of Parkinson’s disease, highlighting a promising new target for treatment.
New evidence shows female genital mutilation is increasingly being carried out by health workers, with one in four girls undergoing the procedure at their hands.
The first comprehensive analysis of three major lung diseases, asthma, chronic obstructive pulmonary disease (COPD), and interstitial lung disease (ILD), across England, Wales, Scotland, and Northern Ireland has been published.
A new analysis by the University of Manchester has investigated how GPs in England endure increased job pressures, insufficient resources, and difficulty in finding locum cover in deprived neighbourhoods.
